Genprex, Inc.
Data quality: 83%
GNPX
Nasdaq
Manufacturing
Chemicals
$1.30
▼
$0.01
(-0.76%)
Mkt Cap: 11.76 M
Price
$1.30
Mkt Cap
11.76 M
Day Range
$1.27 — $1.36
52-Week Range
$1.26 — $55.00
Volume
347,675
Open $1.29
50D / 200D Avg
$2.04
36.42% below
50D / 200D Avg
$6.88
81.10% below
Quick Summary
Key Takeaways
Negative free cash flow of -15.31 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-1503.38%
Below sector avg (-51.02%)
ROIC-1020.59%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.67
Interest CoverageN/A
Valuation
PE (TTM)
-0.72
Above sector avg (-1.98)
P/B Ratio15.31
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (44 peers)
Peer Comparison
vs Manufacturing sector median (44 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.7 | -2.0 |
| P/B | 15.3 | 5.1 |
| ROE % | -1503.4 | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -16.23 M |
| ROE | -1503.38% | ROA | -439.21% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -15.31 M |
| ROIC | -1020.59% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.67 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | -836,605 | Tangible Book Value | 767,807 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.72 | Forward P/E | N/A |
| P/B Ratio | 15.31 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -130.22% | ||
| Market Cap | 11.76 M | Enterprise Value | 10.65 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | -1.69 | OCF / Share | -1.69 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 94.35% |
| SBC-Adj. FCF | -15.92 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -16.23 M | -21.11 M | -30.86 M | -23.74 M | -19.60 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -15.52 M | -21.17 M | -31.08 M | -23.83 M | -19.60 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 9.43 M | 10.54 M | 17.62 M | 11.51 M | 8.61 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0.0 | 2,650.0 | 0.0 | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 10.16 M | 4.12 M | 10.67 M | 25.09 M | 42.86 M |
| Total Liabilities | 2.20 M | — | — | 2.46 M | — |
| Shareholders' Equity | 7.96 M | 1.62 M | 7.42 M | 22.27 M | 41.28 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 7.83 M | 1.60 M | 6.74 M | — | — |
| Current Assets | 8.36 M | 2.08 M | 7.53 M | 21.47 M | 39.14 M |
| Current Liabilities | 2.17 M | 2.50 M | 3.25 M | 2.81 M | 1.59 M |
{"event":"ticker_viewed","properties":{"ticker":"GNPX","listing_kind":"stock","pathname":"/stocks/gnpx","exchange":"Nasdaq","country":"US"}}